Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PALAESTRA: Palliative Radiotherapy and Chemotherapy in Esophageal Adenocarcinoma
NCT02241499Phase 2Completed
- Sponsor
- Skåne University Hospital
- Start
- Oct 2014
- Primary completion
- May 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, fluorouracil in esophageal adenocarcinoma (EAC), adenocarcinoma of the esophagogastric junction (AEG), sponsored by Skåne University Hospital. Started Oct 2014; status: completed.
02
Drugs
oxaliplatinfluorouracil
03
Conditions
esophageal adenocarcinoma (EAC)adenocarcinoma of the esophagogastric junction (AEG)
Beyond the preview
Go deeper on NCT02241499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02241499.